NCT03520751: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 4 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03520751 |
|---|---|
| Title | Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 30, 2025 |
| Completion date | April 30, 2028 |
| Required reporting date | April 30, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |